Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Neurology

Biology and Symptoms: How Krabbe Disease Affects the Body

At a Glance

Krabbe disease is caused by a GALC gene mutation that creates a toxic buildup of psychosine, which destroys the protective myelin insulation around nerves. Symptoms depend heavily on the age of onset, with early infantile Krabbe causing extreme irritability, stiffness, and rapid developmental loss.

Understanding how Krabbe disease works inside the body can help you make sense of the symptoms your child is experiencing. At its core, Krabbe is a “cellular housekeeping” problem that leads to a breakdown of the nervous system’s communication lines.

The Biological Mechanism: A Toxic Buildup

Every cell in the body uses enzymes to break down waste products. In Krabbe disease, a mutation in the GALC gene means the body cannot produce enough of an enzyme called galactosylceramidase [1][2].

  • The Toxin: Without this enzyme, a specific fat called psychosine builds up. While some fats are healthy, psychosine is a “biological poison” in high amounts [3][4].
  • The Destruction of Myelin: Psychosine is extremely toxic to the cells that create myelin, the protective insulation around nerves. It destroys these “insulation-making” cells in both the Central Nervous System (the brain and spinal cord) and the Peripheral Nervous System (the nerves that connect the spine to the rest of the body) [2][4].
  • Globoid Cells: As the body tries to clean up the undigested fats, immune cells (macrophages) swell up and become “globoid cells.” These large, abnormal cells are a hallmark of the disease and contribute to inflammation in the brain [5][5].

Symptoms by Subtype: The Relationship of Timing

The age at which symptoms first appear is the most important factor in predicting how aggressive the disease will be. Generally, the earlier the onset, the faster the progression [6].

Early Infantile Krabbe (Onset < 6 Months)

This is the most common form, accounting for approximately 85-90% of cases [7]. It typically progresses through three stages:

  1. Stage 1: Extreme irritability, “unconsolable” crying, feeding difficulties, and slight stiffness. These are often misdiagnosed as colic, gastroesophageal reflux (GERD), or simple feeding intolerances [8][9].
  2. Stage 2: Rapid developmental backward steps (regression), intense muscle stiffness (hypertonicity), and sudden jerking movements. At this stage, it is sometimes mistaken for cerebral palsy [9][10].
  3. Stage 3: Loss of vision, hearing, and the ability to move. The muscles eventually become very limp (hypotonia), and the child loses awareness of their surroundings [8].

Late-Onset Krabbe (Late Infantile, Juvenile, & Adult)

When the disease begins after 6 months of age, the symptoms are often different and the progression is slower:

  • Late Infantile (6 months – 3 years): Often begins with irritability and a change in walking (gait).
  • Juvenile (3 – 16 years): May first appear as vision problems, tremors, or difficulty with coordination.
  • Adult-Onset (> 16 years): Symptoms are often milder and can include “cramping” in the legs, muscle weakness, or a loss of feeling in the hands and feet (peripheral neuropathy) [11][12][13].

Why Early Symptoms Are Often Missed

Because the earliest signs—crying and stiffness—are common in many healthy babies, it is very easy for doctors to overlook Krabbe initially. If a baby’s irritability is “unconsolable” or if they lose a skill they previously had (like holding their head up), it is a signal that the nerves may be losing their myelin insulation and requires immediate investigation [8][10].

Common questions in this guide

Why are the early symptoms of Krabbe disease often misdiagnosed?
Early signs of Krabbe disease, such as unconsolable crying, extreme irritability, and feeding issues, are very common in healthy babies. Because of this overlap, the condition is often initially mistaken for common issues like colic or severe acid reflux.
What causes the nerve damage in Krabbe disease?
A mutation in the GALC gene prevents the body from producing enough of an essential enzyme. This leads to a toxic buildup of a fat called psychosine, which attacks and destroys the protective myelin insulation surrounding the nerves in the brain and body.
How does the age of onset affect the progression of Krabbe disease?
The age when symptoms first appear is the strongest predictor of disease progression. Generally, the earlier the onset, the more aggressive the disease. Early infantile cases progress very rapidly, while late-onset cases in older children or adults tend to develop much more slowly.
What are the stages of early infantile Krabbe disease?
It typically moves through three stages. It starts with unconsolable crying and slight stiffness, progresses to sudden jerking movements and the rapid loss of developmental milestones, and eventually leads to severe muscle weakness and a loss of vision and hearing.
How can I tell if the disease is affecting the peripheral nervous system?
You should monitor for signs of peripheral neuropathy, which affects the nerves in the arms and legs. In older children and adults, this can present as leg cramping, unexplained muscle weakness, or a loss of feeling in the hands and feet.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my child's current stiffness caused by spasticity or something else, and how can we best manage that discomfort?
  2. 2.Are my child's peripheral nerves (the ones in the arms and legs) affected yet, and how do we monitor for neuropathy?
  3. 3.What are the common misdiagnoses for this stage of the disease, and how can we be sure it's not something like reflux?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Incidental magnetic resonance imaging findings leading to an unusual diagnosis: Adult onset Krabbe disease.

    Paiva ARB, Fonseca Neto RE, Afonso CL, et al.

    European journal of neurology 2022; (29(6)):1859-1862 doi:10.1111/ene.15298.

    PMID: 35212100
  2. 2

    Advanced biomaterials for rare Krabbe disease: galactocerebrosidase scaffolds in demyelinating lesions.

    Ashraf A, Ashraf H, Fatima M, et al.

    Annals of medicine and surgery (2012) 2025; (87(12)):9185-9186 doi:10.1097/MS9.0000000000004240.

    PMID: 41377241
  3. 3

    Rare Saposin A deficiency: Novel variant and psychosine analysis.

    Calderwood L, Wenger DA, Matern D, et al.

    Molecular genetics and metabolism 2020; (129(2)):161-164 doi:10.1016/j.ymgme.2019.08.001.

    PMID: 31439510
  4. 4

    Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signalling.

    O'Sullivan C, Dev KK

    Journal of cell science 2015; (128(21)):3878-87 doi:10.1242/jcs.169342.

    PMID: 26359302
  5. 5

    Human iPSC-derived myelinating organoids and globoid cells to study Krabbe disease.

    Evans LMP, Gawron J, Sim FJ, et al.

    PloS one 2024; (19(12)):e0314858 doi:10.1371/journal.pone.0314858.

    PMID: 39636943
  6. 6

    Clinical characteristics of 248 patients with Krabbe disease: quantitative natural history modeling based on published cases.

    Komatsuzaki S, Zielonka M, Mountford WK, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2019; (21(10)):2208-2215 doi:10.1038/s41436-019-0480-7.

    PMID: 30899093
  7. 7

    Hospitalization Burden and Incidence of Krabbe Disease.

    Ghabash G, Wilkes J, Barney BJ, Bonkowsky JL

    Journal of child neurology 2022; (37(1)):12-19 doi:10.1177/08830738211027717.

    PMID: 34670440
  8. 8

    Peripheral Neuropathy as an Early Marker in Newborn-Screened Krabbe Disease: The Value of Pre-Confirmatory Neurophysiological Testing.

    Gnanakumar A, Aljaberi R, Laney DA, et al.

    Journal of the peripheral nervous system : JPNS 2025; (30(3)):e70040 doi:10.1111/jns.70040.

    PMID: 40560063
  9. 9

    Compound Galactosylceramidase Gene (GALC) Heterozygosity in a Boy with Infantile Krabbe Disease (KD).

    Gucev Z, Tasic V

    Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) 2015; (36(3)):99-101.

    PMID: 27442402
  10. 10

    Adolescent-onset Krabbe disease with an initial diagnosis of multiple sclerosis and a novel mutation.

    Tomás J, Durães J, Lacerda L, Macário MC

    BMJ case reports 2015; (2015()).

    PMID: 26396125
  11. 11

    Pathogenic Variants in GALC Gene Correlate With Late Onset Krabbe Disease and Vision Loss: Case Series and Review of Literature.

    Bascou NA, Beltran-Quintero ML, Escolar ML

    Frontiers in neurology 2020; (11()):563724 doi:10.3389/fneur.2020.563724.

    PMID: 33178108
  12. 12

    [A case of adult-onset Krabbe disease diagnosed by galactocerebrosidase gene mutations, presenting with an atypical phenotype].

    Honkawa Y, Kuwagaki S, Hayashida H, et al.

    Rinsho shinkeigaku = Clinical neurology 2025; (65(11)):808-812 doi:10.5692/clinicalneurol.cn-002148.

    PMID: 41110956
  13. 13

    Enlargement of the brachial plexus on magnetic resonance imaging: a novel finding in adult-onset Krabbe disease.

    Hiyama T, Masumoto T, Hara T, et al.

    BJR case reports 2016; (2(3)):20150213 doi:10.1259/bjrcr.20150213.

    PMID: 30459965

This page provides educational information about the biology and symptoms of Krabbe disease. It is for informational purposes only and does not replace professional medical advice or consultation with your pediatric neurologist.

Get notified when new evidence is published on Krabbe disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.